194 related articles for article (PubMed ID: 8358391)
1. Freeze-drying of cephalothin sodium: granularly agglomerated crystallization during freezing. I.
Suzuki Y; Takeda T; Inazu K; Sakamoto T
Biol Pharm Bull; 1993 Apr; 16(4):402-6. PubMed ID: 8358391
[TBL] [Abstract][Full Text] [Related]
2. [Crystallization and subsequent freeze-drying of cephalothin sodium by seeding method].
Takeda T; Suzuki Y; Inazu K; Sakamoto T; Maekawa H
Yakugaku Zasshi; 1989 Jun; 109(6):395-401. PubMed ID: 2810058
[TBL] [Abstract][Full Text] [Related]
3. Freeze-drying of cephalothin sodium: granularly agglomerated crystallization during freezing. II.
Suzuki Y; Takeda T; Inazu K; Sakamoto T
Biol Pharm Bull; 1993 Apr; 16(4):407-13. PubMed ID: 8358392
[TBL] [Abstract][Full Text] [Related]
4. [Non-crystallinity determination by thermal analysis of freeze-dried cephalothin sodium].
Suzuki Y; Takeda T; Inazu K; Sakamoto T; Maekawa H
Yakugaku Zasshi; 1989 Jun; 109(6):388-94. PubMed ID: 2810057
[TBL] [Abstract][Full Text] [Related]
5. Phase transitions of glycine in frozen aqueous solutions and during freeze-drying.
Pyne A; Suryanarayanan R
Pharm Res; 2001 Oct; 18(10):1448-54. PubMed ID: 11697471
[TBL] [Abstract][Full Text] [Related]
6. The physical state of nafcillin sodium in frozen aqueous solutions and freeze-dried powders.
Milton N; Nail SL
Pharm Dev Technol; 1996 Oct; 1(3):269-77. PubMed ID: 9552309
[TBL] [Abstract][Full Text] [Related]
7. Crystallization of cephalothin sodium during lyophilization from tert-butyl alcohol-water cosolvent system.
Telang C; Suryanarayanan R
Pharm Res; 2005 Jan; 22(1):153-60. PubMed ID: 15771242
[TBL] [Abstract][Full Text] [Related]
8. Freeze-drying using vacuum-induced surface freezing.
Kramer M; Sennhenn B; Lee G
J Pharm Sci; 2002 Feb; 91(2):433-43. PubMed ID: 11835203
[TBL] [Abstract][Full Text] [Related]
9. Raffinose crystallization during freeze-drying and its impact on recovery of protein activity.
Chatterjee K; Shalaev EY; Suryanarayanan R
Pharm Res; 2005 Feb; 22(2):303-9. PubMed ID: 15783079
[TBL] [Abstract][Full Text] [Related]
10. Investigation of PEG crystallization in frozen and freeze-dried PEGylated recombinant human growth hormone-sucrose systems: implications on storage stability.
Bhatnagar BS; Martin SWH; Hodge TS; Das TK; Joseph L; Teagarden DL; Shalaev EY; Suryanarayanan R
J Pharm Sci; 2011 Aug; 100(8):3062-3075. PubMed ID: 21491456
[TBL] [Abstract][Full Text] [Related]
11. The effect of additives on the crystallization of cefazolin sodium during freeze-drying.
Pyne A; Suryanarayanan R
Pharm Res; 2003 Feb; 20(2):283-91. PubMed ID: 12636169
[TBL] [Abstract][Full Text] [Related]
12. Low temperature properties of lyophilized solutions and their influence on lyophilization cycle design: pentamidine isethionate.
Williams NA; Schwinke DL
J Pharm Sci Technol; 1994; 48(3):135-9. PubMed ID: 8069514
[TBL] [Abstract][Full Text] [Related]
13. Formulation Screening and Freeze-Drying Process Optimization of Ginkgolide B Lyophilized Powder for Injection.
Liu D; Galvanin F; Yu Y
AAPS PharmSciTech; 2018 Feb; 19(2):541-550. PubMed ID: 28849380
[TBL] [Abstract][Full Text] [Related]
14. Effects of freeze-dry processing conditions on the crystallization of pentamidine isethionate.
Chongprasert S; Griesser UJ; Bottorff AT; Williams NA; Byrn SR; Nail SL
J Pharm Sci; 1998 Sep; 87(9):1155-60. PubMed ID: 9724570
[TBL] [Abstract][Full Text] [Related]
15. A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying.
de Waard H; Hinrichs WL; Frijlink HW
J Control Release; 2008 Jun; 128(2):179-83. PubMed ID: 18423767
[TBL] [Abstract][Full Text] [Related]
16. Effects of formulation and process factors on the crystal structure of freeze-dried Myo-inositol.
Izutsu K; Yomota C; Okuda H; Kawanishi T; Yamaki T; Ohdate R; Yu Z; Yonemochi E; Terada K
J Pharm Sci; 2014 Aug; 103(8):2347-55. PubMed ID: 24916801
[TBL] [Abstract][Full Text] [Related]
17. Phase transitions in frozen systems and during freeze-drying: quantification using synchrotron X-ray diffractometry.
Varshney DB; Sundaramurthi P; Kumar S; Shalaev EY; Kang SW; Gatlin LA; Suryanarayanan R
Pharm Res; 2009 Jul; 26(7):1596-606. PubMed ID: 19326191
[TBL] [Abstract][Full Text] [Related]
18. Crystalline to amorphous transition of disodium hydrogen phosphate during primary drying.
Pyne A; Chatterjee K; Suryanarayanan R
Pharm Res; 2003 May; 20(5):802-3. PubMed ID: 12751637
[TBL] [Abstract][Full Text] [Related]
19. Physical characterization of meso-erythritol as a crystalline bulking agent for freeze-dried formulations.
Fujii K; Izutsu K; Kume M; Yoshino T; Yoshihashi Y; Sugano K; Terada K
Chem Pharm Bull (Tokyo); 2015; 63(5):311-7. PubMed ID: 25948324
[TBL] [Abstract][Full Text] [Related]
20. Existence of a mannitol hydrate during freeze-drying and practical implications.
Yu L; Milton N; Groleau EG; Mishra DS; Vansickle RE
J Pharm Sci; 1999 Feb; 88(2):196-8. PubMed ID: 9950638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
